Skip to main content
SpringerLink
Log in

Biodistribution and tumour localisation of a daunomycin-monoclonal antibody conjugate in nude mice with human tumour xenografts

  • Original Articles
  • Published:
Cancer Immunology, Immunotherapy Aims and scope Submit manuscript

Summary

The blood kinetics and tissue distribution of a conjugate of daunomycin and a monoclonal antibody (791T/36) have been examined in mice, including nude mice with human tumour xenografts reactive with the antibody. For this the antibody moiety of the conjugate was labelled with 125I and the drug moiety assayed by radioimmunoassay. After radioiodination, the preparation had an immunoreactive fraction in isotopic binding tests with 791T cells of 74%. Both drug and antibody moieties were precipitable with anti-mouse Ig anti-serum. Following i.v. injection, blood clearance of the two components of the conjugate was essentially identical, and with the serumborne conjugate both radiolabel and drug were co-precipitable. In mice with 791T xenografts, the tumour showed localisation of both drug and antibody moieties and at the time of analysis (3 days) tumour levels of drug were over 100 times those seen with free drug. In parallel studies with mice with antigen negative xenografts, there was no preferential localisation of antibody or drug moieties of the conjugate. These studies have shown in vivo stability of this conjugate, and site-specific targetting of an anti-tumour anthracycline.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Arcamone F (1987) Clinically useful doxorubicin analogues. Cancer Treat Rev 14:159

    Google Scholar 

  2. Armitage NC, Perkins AC, Pimm MV, Wastie ML, Baldwin RW, Hardcastle JD (1985) Imaging of primary and metastic colorectal cancer using an 111In-labelled anti-tumour monoclonal antibody (791T/36). Nucl Med Commun 6:623

    Google Scholar 

  3. Baldwin RW, Byers VS (1987) Monoclonal antibodies and immunoconjugates for cancer treatment. In: Cancer chemotherapy and biological response modifiers. Annual 9. Elsevier, p 409

  4. Baldwin RW, Embleton MJ, Gallego J, Garnett M, Pimm MV, Price MR (1986) Monoclonal antibody drug conjugates for cancer therapy. In: Monoclonal antibodies in cancer: advances in diagnosis and treatment. Futura Publishing Co Inc, New York, p 215

    Google Scholar 

  5. Bernstein A, Hurwitz E, Maron R, Arnon R, Sela M, Wilchek M (1978) Higher antitumour efficacy of daunomycin when linked to dextran. In vivo and in vitro studies. J Natl Cancer Inst 60:379

    Google Scholar 

  6. Byers VS, Pimm MV, Pawluczyk IZA, Lee HM, Scannon PJ, Baldwin RW (1987) Biodistribution of ricin toxin A chainmonoclonal antibody 791T/36 immunotoxin and influence of hepatic blocking agents. Cancer Res 47:5277

    Google Scholar 

  7. Clegg JA, Pimm MV, Garnett MC, Baldwin RW (1988) Biodistribution and tumour localization of a methotrexatemonoclonal antibody 791T/36 conjugate in nude mice with human tumour xenografts. Int J Cancer (in press)

  8. Covell DG, Barbet J, Holton OD, Black CDV, Parker RJ, Weinstein JW (1986) Pharmacokinetics of monoclonal immunoglobulin G1, F(ab')2 and Fab' in mice. Cancer Res 46:3969

    Google Scholar 

  9. Gallego J, Price MR, Baldwin RW (1984) Preparation of four daunomycin-antibody 791T/36 conjugates with anti-tumour activity. Int J Cancer 33:737

    Google Scholar 

  10. Ghose T, Blair AH (1987) The design of cytotoxic-agent-antibody conjugates. CRC Crit Rev Therapeutic Drug Carrier Systems 3:263

    Google Scholar 

  11. Lindmo T, Boven E, Cuttitta F, Fedorko J, Bunn PA (1984) Determination of the immunoreactive fraction of radiolabelled monoclonal antibody by linear extrapolation to binding at infinite antigen excess. J Immunol Methods 72:77

    Article  CAS  PubMed  Google Scholar 

  12. Monsigny M, Kieda C, Roche AC, Delmoite F (1980) Preparation and biological properties of a covalent anti-tumour drug-arm-carrier (DAC conjugate). FEBS Lett 119:181

    Google Scholar 

  13. Ognumuyiwa Y, Clegg JA, Pimm MV, Price MR, Baldwin RW (1987) Comparative biodistribution of daunomycin-HSA-monoclonal antibody conjugates with different linkages. Br J Cancer 56:186

    Google Scholar 

  14. Piall EM, Aherne GW, Marks V (1982) Evaluation of a commercially available kit for the measurement of doxorubicin (Adriamycin) in plasma. Clin Chem 28:119

    Google Scholar 

  15. Pimm MV (1987) Immunoscintigraphy: tumour detection with radiolabelled anti-tumour monoclonal antibodies. In: Immunology of malignant diseases. MTP Press, Lancaster, Boston, p 21

    Google Scholar 

  16. Pimm MV, Baldwin RW (1985) Localization of an anti-tumour monoclonal antibody in human tumour xenografts: kinetic and quantitative studies with 791T antibody. In: Monoclonal antibodies for cancer detection and therapy. Academic Press, New York, p 97

    Google Scholar 

  17. Pimm MV, Embleton MJ, Perkins AC, Price MR, Robins RA, Robinson GR, Baldwin RW (1982) In vivo localization of anti-osteogenic sarcoma 791T monoclonal antibody in osteogenic sarcoma xenografts. Int J Cancer 30:75

    Google Scholar 

  18. Pimm MV, Clegg JA, Caten JE, Ballantyne KD, Perkins AC, Garnett MC, Baldwin RW (1987) Biodistribution of methotrexate-monoclonal antibody conjugates and complexes: experimental and clinical studies. Cancer Treat Rev 14:411

    Google Scholar 

  19. Pimm MV, Clegg JA, Baldwin RW (1987) Biodistribution and tumour localisation of radiolabelled monoclonal antibody during continuous infusion in nude mice with human tumour xenografts. Eur J Cancer Clin Oncol 23:521

    Google Scholar 

  20. Powell MC, Perkins AC, Pimm MV, Jetaily A, Wastie ML, Durrant L, Baldwin RW, Symonds EM (1987) Diagnostic imaging of gynaecological tumours using the monoclonal antibody 791T/36 Am J Obstet Gynecol 157:28

    Google Scholar 

  21. Rowland GF, Simonds RG, Gore VA, Marsden CH, Smith W (1986) Drug localisation and growth inhibition studies of vindesine-monoclonal anti-CEA conjugate in a human tumour xenograft. Cancer Immunol Immunother 21:183

    Google Scholar 

  22. Rusconi A, Di Fronzo G, Di Marco A (1968) Distribution of tritiated daunomycin in normal rats, Cancer Chemother Rep 52:331

    Google Scholar 

  23. Seymour LW, Duncan R, Kopeckova P, Kopecek J (1987) Daunomycin and adriamycin-N-(2-hydroxypropyl) methacrylamide copolymer conjugate: toxicity reduction by improved drug delivery. Cancer Treat Rev 14:319

    Google Scholar 

  24. Zunino F, Giuliani F, Savi G, Dasdia T, Gambetta R (1982) Anti-tumour activity of daunorubicin linked to poly-L-aspartic acid. Int J Cancer 30:465

    Google Scholar 

  25. Yesair DW, Thayer PS, McNitt S, Teague K (1980) Comparative uptake, metabolism and retention of anthracyclines by tumors growing in vitro and in vivo. Eur J Cancer 16:401

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Cancer Research Campaign Laboratories, University of Nottingham, NG7 2RD, Nottingham, UK

    M. V. Pimm, M. A. Paul, Y. Ogumuyiwa & R. W. Baldwin

Authors
  1. M. V. Pimm
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. A. Paul
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Y. Ogumuyiwa
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. R. W. Baldwin
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pimm, M.V., Paul, M.A., Ogumuyiwa, Y. et al. Biodistribution and tumour localisation of a daunomycin-monoclonal antibody conjugate in nude mice with human tumour xenografts. Cancer Immunol Immunother 27, 267–271 (1988). https://doi.org/10.1007/BF00205450

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00205450

Keywords

Search

Navigation